JP2007513059A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513059A5 JP2007513059A5 JP2006529497A JP2006529497A JP2007513059A5 JP 2007513059 A5 JP2007513059 A5 JP 2007513059A5 JP 2006529497 A JP2006529497 A JP 2006529497A JP 2006529497 A JP2006529497 A JP 2006529497A JP 2007513059 A5 JP2007513059 A5 JP 2007513059A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- gastrin
- pharmaceutical composition
- composition according
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2003/016660 WO2003100024A2 (en) | 2002-05-24 | 2003-05-27 | Treatment for diabetes |
| PCT/CA2004/000769 WO2004105780A2 (en) | 2003-05-27 | 2004-05-27 | Compositions comprising gastrin compounds and their use in diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513059A JP2007513059A (ja) | 2007-05-24 |
| JP2007513059A5 true JP2007513059A5 (https=) | 2007-07-12 |
Family
ID=33488788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006529497A Pending JP2007513059A (ja) | 2003-05-27 | 2004-05-27 | ガストリン化合物を含む組成物および糖尿病におけるそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1648495A2 (https=) |
| JP (1) | JP2007513059A (https=) |
| CN (1) | CN1829528A (https=) |
| AU (1) | AU2004243541A1 (https=) |
| BR (1) | BRPI0410710A (https=) |
| CA (1) | CA2527186A1 (https=) |
| MX (1) | MXPA05012605A (https=) |
| NO (1) | NO20055582L (https=) |
| PL (1) | PL379145A1 (https=) |
| RU (1) | RU2005140518A (https=) |
| WO (1) | WO2004105780A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1486204A (zh) | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物 |
| DE60329724D1 (de) | 2002-06-07 | 2009-11-26 | Waratah Pharmaceuticals Inc | Methoden und Kompositionen um Diabetes zu behandeln |
| EP1837031B1 (en) | 2002-06-07 | 2009-10-14 | Waratah Pharmaceuticals, Inc. | Compositions and methods for treating diabetes |
| WO2005072045A2 (en) * | 2004-01-30 | 2005-08-11 | Waratah Pharmaceuticals, Inc. | The combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| WO2008106779A1 (en) * | 2007-03-02 | 2008-09-12 | Waratah Pharmaceuticals Inc. | Gastrin compound for diabetes treatment |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
| EP1132091A1 (en) * | 1994-01-24 | 2001-09-12 | The General Hospital Corporation | Treatment for diabetes |
| CN1486204A (zh) * | 2001-01-12 | 2004-03-31 | ������˹ҩƷ��˾ | 用于胰岛再生的含胃泌素/cck受体配基及egf受体配基的组合物 |
| AU2003283004A1 (en) * | 2002-10-22 | 2004-05-13 | Waratah Pharmaceuticals, Inc. | Treatment of diabetes |
-
2004
- 2004-05-27 CN CNA200480022042XA patent/CN1829528A/zh active Pending
- 2004-05-27 AU AU2004243541A patent/AU2004243541A1/en not_active Withdrawn
- 2004-05-27 PL PL379145A patent/PL379145A1/pl not_active Application Discontinuation
- 2004-05-27 BR BRPI0410710-1A patent/BRPI0410710A/pt not_active IP Right Cessation
- 2004-05-27 CA CA002527186A patent/CA2527186A1/en not_active Abandoned
- 2004-05-27 WO PCT/CA2004/000769 patent/WO2004105780A2/en not_active Ceased
- 2004-05-27 JP JP2006529497A patent/JP2007513059A/ja active Pending
- 2004-05-27 EP EP04737749A patent/EP1648495A2/en not_active Withdrawn
- 2004-05-27 RU RU2005140518/15A patent/RU2005140518A/ru not_active Application Discontinuation
- 2004-05-27 MX MXPA05012605A patent/MXPA05012605A/es not_active Application Discontinuation
-
2005
- 2005-11-25 NO NO20055582A patent/NO20055582L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10335462B2 (en) | Use of long-acting GLP-1 peptides | |
| US20230414773A1 (en) | Elp fusion proteins for controlled and sustained release | |
| EP2324853B1 (en) | Lixisenatide as add-on to metformin in the treatment of diabetes type 2 | |
| EP2329848B2 (en) | Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes | |
| JP2006506386A5 (https=) | ||
| WO2009048945A1 (en) | Rapid mucosal gel or film insulin compositions | |
| CN103167878A (zh) | 采用在不同注射时间间隔给予的胰岛素注射剂治疗糖尿病 | |
| US20240366533A1 (en) | Sublingual Epinephrine Tablets | |
| US20250319163A1 (en) | Treatment of type 2 diabetes mellitus | |
| JP2007513059A5 (https=) | ||
| RU2005140518A (ru) | Композиции и способы, включающие соединения гастрина | |
| Chakraborti | Exenatide: a new promising antidiabetic agent | |
| CA2666846C (en) | Method of restoring the incretin effect | |
| Pitocco et al. | Unmet needs among patients with type 2 diabetes and secondary failure to oral anti-diabetic agents | |
| Kang | Current therapeutic agents and anesthetic considerations for diabetes mellitus | |
| AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) | |
| EP4090351B1 (en) | Dosing regimen of glp-1 | |
| Chaurasia | A 100 Years Journey of Insulin | |
| TW202529797A (zh) | Ｇｌｐ－１類似物治療代謝疾病的方法及醫藥用途 | |
| Liebelt | Newer antidotal therapies for pediatric poisonings | |
| CN106924723B (zh) | 经口腔黏膜给药的含人胰高血糖素样肽-1类似物的药物组合物 | |
| JP2017081910A (ja) | 血糖恒常性を維持するための医薬組成物 | |
| ES2724731T3 (es) | Composición farmacéutica | |
| Ahammad et al. | Incretin-Based Antidiabetic Agents: A New Option for Type-2 Diabetes Mellitus | |
| Plengvidhya | Novel Therapeutic Approach of Type 2 Diabetes Mellitus |